Medical Technology Assessment (HTA) is a systematic assessment of the conditions for and the consequences of using medical technology. Medical Technology is methods and equipment used in the detection, diagnosis, treatment, care, rehabilitation and prevention of health problems.

For patients, this means that they receive the treatment that provides the greatest possible effect and the best patient experience and where there is a solid scientific foundation, which documents that the treatment is secure and well-tested.

A Health Technology Assessment (HTA) assesses the consequences of a medical technology on four main areas: Technology, the patient, the organization, and the economy.

When evaluating telemedicine, we use the model MAST (Model for Assessment of Telemedicine), which is based on MTV.

The HTA unit at Odense University Hospital (OUH) is linked to innovation and research projects at OUH, but can also be associated with projects at other hospitals etc. in Denmark. HTA employees are included at all levels from guidance / supervision to project management with responsibility for the project’s progress.


What can we do?

The HTA unit’s competencies include:

  • Evaluation of telemedicine and welfare technology solutions
  • Systematic literature search
  • Health economics analyzes (including register studies)
  • Patient experience studies
  • Organizational analysis
  • Preparation of HTA reports
  • Preparation of mini-MTVs
  • Advice (assistance regarding project design, method and evaluation approaches)
  • Education in HTA and mini-HTA
  • Business cases

MAST (Model for Assesment of Telemedicine)

Model for Assessment of Telemedicine (MAST) provides a solid foundation for deciding on the introduction and use of telemedicine. It does this by describing the effect of telemedicine on:

  1. The patient and the technology
  2. patient Safety
  3. Clinical effect
  4. The patient’s perspective
  5. Economic aspects
  6. Organizational aspects
  7. Legal and ethical aspects

Hear about the possibilities for a presentation on MAST

MAST is developed by Kristian Kidholm, research manager at the Center for Innovative Medical Technology (CIMT). The model is the most widely used framework for evaluating telemedicine in Europe. The European Commission recommends the model for evaluating telemedicine projects.

About MAST


MAST is the result of the EU project MethoTelemed, which was completed in 2010. Read the final report from the project MethoTelemed.

In Denmark, the MAST model has also been adopted. In 2014, the National Health IT (NSI) and the National Coordination Group for Telemedicine took the initiative to prepare a new checklist that managers in the health service can use when they decide on which telemedicine solutions they will introduce. The checklist has been prepared in collaboration with the unit for Medical Technology Assessment in CIMT. It is based on the Danish experiences with both mini-HTA (Medical Technology Assessment) and MAST.

In March 2015, the Region of Southern Denmark’s Health IT Committee decided that in future the checklist should be compulsory in all Region Syddanmark’s decisions on the introduction of telemedicine solutions. Read more about the checklist.

MAST is used to evaluate telemedicine and e-health technologies in Denmark. WelfareTech, VihTek Knowledge Center for Assistive Technology and Welfare Technology in the Capital Region of Denmark, Danish Technological Institute, Welfare Innovation Zealand, Laboratory for Welfare Technologies – Telehealth & Telerehabilitation at Aalborg University, the Health Data Board and MedCom.

The MAST model is also being widespread in other areas than in hospitals and has, among other things, been used to evaluate a large welfare technology project in collaboration between 11 municipalities in Region Sjælland.